Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Clinics in Colon and Rectal Surgery
|
September 7, 2018
Small Bowel Adenocarcinoma
Emerson Y Chen, Gina M Vaccaro
Cancer Nursing
|
August 15, 2014
Patients With Hepatocellular Carcinoma Near the End of Life: A Longitudinal Qualitative Study of Their Illness Experiences
Lissi Hansen, Susan J Rosenkranz, Gina M Vaccaro, et al.
Diseases of the Colon and Rectum
|
March 9, 2016
Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer
John I Young, Solange Mongoue-Tchokote, Nicole Wieghard, et al.
American Journal of Surgery
|
April 8, 2017
Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma
Patrick J McLaren, Anthony P Barnes, Willy Z Terrell, et al.
Journal of Gastrointestinal Cancer
|
February 23, 2020
Effect of Time to Surgery of Colorectal Liver Metastases on Survival
Emerson Y Chen, Skye C Mayo, Thomas Sutton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 5, 2013
Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy
Ilia Gur, Brian S Diggs, Jesse A Wagner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 14, 2017
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer
Patrick J McLaren, Nathan W Bronson, Kyle D Hart, et al.
Anticancer Research
|
December 29, 2018
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
Matthew R Kearney, Emerson Y Chen, Gina M Vaccaro, et al.
JAMA Surgery
|
September 15, 2016
Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
Kelly R Haisley, Amy E Laird, Nima Nabavizadeh, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Clinics in Colon and Rectal Surgery
|
September 7, 2018
Small Bowel Adenocarcinoma
Emerson Y Chen, Gina M Vaccaro
Cancer Nursing
|
August 15, 2014
Patients With Hepatocellular Carcinoma Near the End of Life: A Longitudinal Qualitative Study of Their Illness Experiences
Lissi Hansen, Susan J Rosenkranz, Gina M Vaccaro, et al.
Diseases of the Colon and Rectum
|
March 9, 2016
Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer
John I Young, Solange Mongoue-Tchokote, Nicole Wieghard, et al.
American Journal of Surgery
|
April 8, 2017
Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma
Patrick J McLaren, Anthony P Barnes, Willy Z Terrell, et al.
Journal of Gastrointestinal Cancer
|
February 23, 2020
Effect of Time to Surgery of Colorectal Liver Metastases on Survival
Emerson Y Chen, Skye C Mayo, Thomas Sutton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 5, 2013
Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy
Ilia Gur, Brian S Diggs, Jesse A Wagner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 14, 2017
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer
Patrick J McLaren, Nathan W Bronson, Kyle D Hart, et al.
Anticancer Research
|
December 29, 2018
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
Matthew R Kearney, Emerson Y Chen, Gina M Vaccaro, et al.
JAMA Surgery
|
September 15, 2016
Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
Kelly R Haisley, Amy E Laird, Nima Nabavizadeh, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Page
of 2